Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rifkin

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Experimental Medicine|November 1, 1992
Application of DNA amplification to pneumocystosis: presence of serum Pneumocystis carinii DNA during human and experimentally induced Pneumocystis carinii pneumoniaN Schluger, T Godwin, K Sepkowitz, et al.
Magnetic Resonance Imaging|January 1, 1990
MR imaging of pulmonary parenchyma and emboli by paramagnetic and superparamagnetic contrast agentsM L Thakur, S Vinitski, D G Mitchell, et al.
The Western Journal of Medicine|July 1, 1988
Malignant melanoma--profile of an epidemicR M Rifkin, M R Thomas, T I Mughal, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|August 26, 2003
Bayesian estimation of transcript levels using a general model of array measurement noiseRon O Dror, Jonathan G Murnick, Nicola J Rinaldi, et al.
Future Oncology (London, England)|November 27, 2023
Plain language review: what are biosimilar medicines and how can they be used to treat people with cancer?Manwar Al-Naqqash, Gilberto Castañeda-Hernández, Shao-Chin Chiang, et al.
Therapeutic Advances in Hematology|February 6, 2019
A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology settingRobert M Rifkin, Rohan Medhekar, E Susan Amirian, et al.
Pharmacoeconomics - Open|October 13, 2019
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple MyelomaRobert M Rifkin, Jill A Bell, Pronabesh DasMahapatra, et al.
Pharmacotherapy|December 26, 2003
Impact of long-acting growth factors on practice dynamics and patient satisfactionRoy A Beveridge, Robert M Rifkin, Ronald J Moleski, et al.
Lancet (London, England)|April 18, 2000
High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda studyR B Weiss, R M Rifkin, F M Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Hodgkin's disease following solid organ transplantationP J Bierman, J M Vose, A N Langnas, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Experimental Medicine|November 1, 1992
Application of DNA amplification to pneumocystosis: presence of serum Pneumocystis carinii DNA during human and experimentally induced Pneumocystis carinii pneumoniaN Schluger, T Godwin, K Sepkowitz, et al.
Magnetic Resonance Imaging|January 1, 1990
MR imaging of pulmonary parenchyma and emboli by paramagnetic and superparamagnetic contrast agentsM L Thakur, S Vinitski, D G Mitchell, et al.
The Western Journal of Medicine|July 1, 1988
Malignant melanoma--profile of an epidemicR M Rifkin, M R Thomas, T I Mughal, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|August 26, 2003
Bayesian estimation of transcript levels using a general model of array measurement noiseRon O Dror, Jonathan G Murnick, Nicola J Rinaldi, et al.
Future Oncology (London, England)|November 27, 2023
Plain language review: what are biosimilar medicines and how can they be used to treat people with cancer?Manwar Al-Naqqash, Gilberto Castañeda-Hernández, Shao-Chin Chiang, et al.
Therapeutic Advances in Hematology|February 6, 2019
A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology settingRobert M Rifkin, Rohan Medhekar, E Susan Amirian, et al.
Pharmacoeconomics - Open|October 13, 2019
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple MyelomaRobert M Rifkin, Jill A Bell, Pronabesh DasMahapatra, et al.
Pharmacotherapy|December 26, 2003
Impact of long-acting growth factors on practice dynamics and patient satisfactionRoy A Beveridge, Robert M Rifkin, Ronald J Moleski, et al.
Lancet (London, England)|April 18, 2000
High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda studyR B Weiss, R M Rifkin, F M Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Hodgkin's disease following solid organ transplantationP J Bierman, J M Vose, A N Langnas, et al.
Pageof 9